Loading the company…
Loading the company…
Families: Incontinence, prolapse & sacral neuromodulation, Peripheral nerve stimulation & intrathecal pumps.
All companies · Product and company coverage
In the last ten years FDA made 7 decisions for Neuspera Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2026 (3). The latest was on 2026-08-21.
| Family | Decisions on record |
|---|---|
| Incontinence, prolapse & sacral neuromodulation | 5 |
| Peripheral nerve stimulation & intrathecal pumps | 2 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-08-21 | PMA | P240031-S005 | Neuspera Sacral Neuromodulation (SNM) System · Labeling Change - Indications/instructions/shelf life/tradename |
| 2026-04-21 | PMA | P240031-S003 | Neuspera Sacral Neuromodulation (SNM) System · Change Design/Components/Specifications/Material |
| 2026-04-03 | PMA | P240031-S004 | Neuspera Sacral Neuromodulation (SNM) System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2025-08-15 | PMA | P240031-S001 |
| Neuspera Sacral Neuromodulation System · Postapproval Study Protocol |
| 2025-06-17 | PMA | P240031 | Neuspera Sacral Neuromodulation System · Stimulator, electrical, implantable, for incontinence |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Neuspera Medical.